In fact, a recent study has reported elevated IL-33 levels in the serum of gastric cancer patients that correlated with several poor prognostic factors, including depth of invasion, distant metastasis, and advanced stage, but not with the classic tumor markers, CEA and CA 19–9[79]. This evidence concerns the gene IL33 and gastric cancer.